We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Butterfly Wings-Inspired Imaging Technique Enables Faster Cancer Diagnosis

By LabMedica International staff writers
Posted on 24 Feb 2025
Print article
Image: Paula Kirya, first author of the study, uses the light-manipulating microstructures of Morpho butterfly wings to assess fibrosis levels in cancer biopsy samples (Photo courtesy of David Baillot/UC San Diego Jacobs School of Engineering)
Image: Paula Kirya, first author of the study, uses the light-manipulating microstructures of Morpho butterfly wings to assess fibrosis levels in cancer biopsy samples (Photo courtesy of David Baillot/UC San Diego Jacobs School of Engineering)

Fibrosis, which refers to the accumulation of fibrous tissue, is a significant characteristic of various diseases, including neurodegenerative conditions, heart disease, and cancer. In oncology, determining the extent of fibrosis in a biopsy can help assess whether a cancer is in its early or advanced stages. However, distinguishing between these stages using current clinical methods is a significant challenge. These methods typically involve staining tissues to highlight key structures in a tumor biopsy, but the results can be subjective—interpretations may vary between pathologists. While more advanced imaging techniques can provide more detailed insights, they often require expensive, specialized equipment that is not available in many clinics. Now, researchers have discovered an unexpected ally in the effort to make cancer diagnosis faster, more accurate, and more accessible worldwide: the Morpho butterfly.

Renowned for its vibrant blue wings, the Morpho butterfly’s brilliance is not due to pigments but to microscopic structures that manipulate light. Researchers at the University of California San Diego (La Jolla, CA, USA) are utilizing these same microstructures to gain detailed insights into the fibrous composition of cancer biopsy samples—without the need for chemical stains or costly imaging systems. In a study published in Advanced Materials, the team demonstrated that by placing a biopsy sample atop a Morpho butterfly wing and observing it under a standard microscope, they could determine whether the tumor’s structure suggests early- or late-stage cancer—without relying on staining or expensive imaging devices. The micro- and nanostructures of the wing interact strongly with polarized light, a type of light that moves in a specific direction. Collagen fibers, which are a vital component of fibrotic tissue, also respond to polarized light, though their signals are weak. By positioning a biopsy sample over a section of a Morpho butterfly wing, the researchers amplified these weak signals, making it easier to examine the density and arrangement of collagen fibers.

The amplified signals can then be interpreted to quantify the density and organization of the collagen fibers in the sample. To achieve this, the researchers developed a mathematical model based on Jones calculus, a technique used to analyze polarized light. The model correlates the intensity of the light with the density and structure of collagen fibers, providing a measurable indicator of fibrosis in the tissue. The researchers applied this method to analyze both collagen-dense and collagen-sparse human breast cancer biopsy samples. Their findings were comparable to conventional staining techniques and a high-cost advanced imaging method. Importantly, this technique can be performed with standard optical microscopes that are already available in most clinics. Additionally, it is more objective and quantitative than existing methods. Although this study focused on breast cancer, the researchers believe this approach could be extended to other fibrotic diseases as well.

“Essentially, we’re trying to expand on these procedures with a stain-free alternative that requires nothing more than a standard optical microscope and a piece of a Morpho wing,” said Paula Kirya, a mechanical engineering graduate student at UC San Diego and the study’s first author. “In many parts of the world, early cancer screening is a challenge because of resource limitations. If we can provide a simpler and more accessible tool, we can help more patients get diagnosed before their cancers reach aggressive stages.”

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
High Performance Centrifuge
CO336/336R

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.